pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells
Author:
Affiliation:
1. State Key Laboratory of Quality Research in Chinese Medicine
2. Institute of Chinese Medical Sciences
3. University of Macau
4. Taipa
5. China
6. Department of Pharmaceutics
7. College of Pharmacy
8. Third Military Medical University
9. Chongqing
Abstract
A pH-sensitive prodrug nanoparticle demonstrated the selective co-delivery of doxorubicin and curcumin into cancer cells with much improved efficacy and safety profile.
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science
Link
http://pubs.rsc.org/en/content/articlepdf/2017/NR/C7NR03611F
Reference38 articles.
1. Novel immune check point inhibiting antibodies in cancer therapy—Opportunities and challenges
2. Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
3. ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses
4. Stimuli-responsive nanocarriers for drug delivery
5. Temperature-responsive polymeric micelles for optimizing drug targeting to solid tumors
Cited by 107 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Doxorubicin-galactomannan nanoconjugates for potential cancer treatment;Carbohydrate Polymers;2024-10
2. B ← N coordination bond reinforced dynamic fluorescence of pH-responsive amphiphile alginate aggregates for anti-counterfeiting;Carbohydrate Polymers;2024-06
3. pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery;Journal of Drug Targeting;2024-05-09
4. Synthesis and characterization of the redox-responsive amphiphilic fluorescent alginate derivatives as the multi-functional hydrophobic anticancer drug delivery system with visualization and sustained release;Materials Today Communications;2024-03
5. Development and evaluation of redox-responsive alginate–SS–ibuprofen derivative based anti-tumor target drug delivery system for the controlled release of doxorubicin;Journal of Drug Delivery Science and Technology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3